A novel approach for nasopharyngeal carcinoma treatment uses phenylbutyrate as a protein kinase C modulator: implications for radiosensitization and EBV-targeted therapy.
Year: 2000
Type: article
Source: PubMed
Authors: Y L Chung, Y H Lee, S H Yen, K H Chi
Institution: Taipei Veterans General Hospital
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2139019174
